PUBLISHER: GlobalData | PRODUCT CODE: 1395950
PUBLISHER: GlobalData | PRODUCT CODE: 1395950
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Immunochemistry Analyzers market for the year 2020 and beyond. Due to their versatility, immunochemistry analyzers are relied upon for diagnosis and monitoring of a range of different conditions including diabetes, infectious disease testing, cancer diagnostics, and cardiac market tests. The immunochemistry analyzer market is large due to its involvement in a broad range of indications and is also being driven by rises in the prevalence of numerous diseases, as well as aging populations. Due to increased demand for lab automation and their continued use for routine diagnostic and patient monitoring purposes, immunochemistry analyzers are expected to increase in market value and will continue to be a primary method for laboratory diagnostic testing, measuring parameters linked to a wide range of diseases such as thyroid disorders, women's health, diabetes, infectious diseases; cardiac markers; and cancer.
Immunochemistry Analyzers model includes Chemiluminescence (CLIA), Immunofluorescence, Enzyme Immuno Assays (EIAs) and Point-Of-Care (POC) Analyzers as sub-segments.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Immunochemistry Analyzers and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Danaher Corp, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, DiaSorin SpA, bioMerieux SA, Siemens Healthineers AG, Quidelortho Corp, Werfen Life Group SAU, Hologic Inc, Quanterix Corp, Meridian Bioscience , Agilent Technologies Inc, Eurofins Scientific SE, Revvity Inc, Tecan Group Ltd, STRATEC SE, BMG Labtech GmbH, Revvity Inc and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable